Trademark: 88866290
Word
MANDARA PHARMA
Status
Dead
Status Code
606
Status Date
Monday, October 31, 2022
Serial Number
88866290
Mark Type
4000
Filing Date
Thursday, April 9, 2020
Published for Opposition
Tuesday, August 4, 2020
Abandoned Date
Monday, October 31, 2022

Trademark Owner History
Mandarapharma, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for oral and topical administration to humans for the treatment of glaucoma, fibromyalgia, anxiety, and depression; topically applied transdermal patches for treatment of diseases and disorders in humans, namely, for use in treatment of post-traumatic stress disorder (PTSD), glaucoma, fibromyalgia, anxiety, and depression; dietary feed supplements for cats, dogs, and horses
44 Genetic analysis and testing services in the nature of genetic testing for medical purposes to select pharmaceutical products and treatments based on genetic tests
MANDARA PHARMACEUTICAL
"PHARMA"

Trademark Events
Oct 31, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 31, 2022
Abandonment - No Use Statement Filed
Mar 30, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 28, 2022
Sou Extension 3 Granted
Mar 28, 2022
Sou Extension 3 Filed
Mar 28, 2022
Sou Teas Extension Received
Oct 1, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 29, 2021
Sou Extension 2 Granted
Sep 29, 2021
Sou Extension 2 Filed
Sep 29, 2021
Sou Teas Extension Received
Mar 30, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 28, 2021
Sou Extension 1 Granted
Mar 28, 2021
Sou Extension 1 Filed
Mar 28, 2021
Sou Teas Extension Received
Sep 29, 2020
Noa E-Mailed - Sou Required From Applicant
Aug 4, 2020
Official Gazette Publication Confirmation E-Mailed
Aug 4, 2020
Published For Opposition
Jul 15, 2020
Notification Of Notice Of Publication E-Mailed
Jul 2, 2020
Assigned To Lie
Jun 29, 2020
Approved For Pub - Principal Register
Jun 29, 2020
Examiner's Amendment Entered
Jun 29, 2020
Notification Of Examiners Amendment E-Mailed
Jun 29, 2020
Examiners Amendment E-Mailed
Jun 29, 2020
Examiners Amendment -Written
Jun 26, 2020
Assigned To Examiner
Apr 17, 2020
New Application Office Supplied Data Entered
Apr 13, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24